Arnold Glazier, M.D.

Chief Science & Medical Officer

Dr. Glazier is responsible for General Oncology's research and development. He has 35+ years of experience in drug design and cancer research and has received patents on multiple anticancer inventions. Dr. Glazier's research focuses on understanding and satisfying the requirements for the specific cure of cancer either without significant patient toxicity or with only reversible patient toxicity. He received his medical degree from Boston University’s 6-year Medical Program at age 22, trained in pediatrics at Johns Hopkins Hospital and Tufts Medical Center, and was an Oncology Research Fellow at Johns Hopkins Oncology Center.